LONG ESSAY: Shock - Diagnosis, Classification, Pathogenesis, Morphology & Evolution (12 Marks)

DIAGNOSIS (1 Mark)

• Rapid pulse (tachycardia)
• Cold, clammy, cyanotic skin
• Tachypnea
• Unconsciousness

CLASSIFICATION OF SHOCK (3 Marks)

• Neurogenic shock - Spinal cord injury causing acute vasodilation
• Anaphylactic shock - IgE-mediated hypersensitivity causing vasodilation and hypotension

In RTA with blood loss, Hypovolemic shock is the diagnosis. It can be further classified based on blood loss (Classes I-IV).

PATHOGENESIS OF SHOCK (3 Marks)

In Hypovolemic Shock (from trauma/hemorrhage):

Compensatory/Neurohormonal Response:

1. Baroreceptor reflexes - detect fall in blood pressure
2. Sympatho-adrenal activation - release of catecholamines (epinephrine, norepinephrine) → tachycardia, peripheral vasoconstriction
3. ADH (Vasopressin) release - promotes water retention
4. Renin-Angiotensin-Aldosterone axis activation - sodium and water retention, vasoconstriction
5. Net effect: Peripheral vasoconstriction → cold, clammy, pale skin; tachycardia; renal fluid conservation
6. Coronary and cerebral vessels are relatively spared - blood is shunted to vital organs (heart and brain)

Progressive Phase:

• If not corrected, persistent oxygen deficit forces cells to shift to anaerobic glycolysis
• Lactic acid accumulates → metabolic lactic acidosis
• Lowered tissue pH blunts vasomotor response → arterioles dilate
• Blood pools in microcirculation → worsening cardiac output
• Endothelial cell hypoxia → DIC (Disseminated Intravascular Coagulation)
• Vital organs begin to fail

Irreversible Phase:

• Widespread cellular injury → lysosomal enzyme leakage
• Myocardial contractile function worsens (increased NO synthesis)
• Ischemic bowel → intestinal bacteria enter circulation → bacteremic/septic shock superimposed
• Renal failure (acute tubular necrosis)
• Downward spiral culminates in death

MORPHOLOGY OF SHOCK (3 Marks)

1. Brain

• Ischemic encephalopathy - neurons are most sensitive to hypoxia
• Neuronal necrosis, especially in watershed zones

2. Heart

• Subendocardial hemorrhage and necrosis
• Myofibril fragmentation
• Contraction band necrosis (due to catecholamine excess)
• In prolonged shock: focal myocardial necrosis

3. Kidneys

• Acute Tubular Necrosis (ATN) - most characteristic lesion
• Tubular epithelial cell necrosis, especially proximal tubules and loop of Henle
• Fibrin thrombi most readily visible in glomeruli (due to DIC)
• Clinically: oliguria, then anuria - acute renal failure

4. Adrenals

• Cortical lipid depletion - reflects increased use of stored lipids for glucocorticoid synthesis in response to stress
• In severe/prolonged shock: adrenocortical hemorrhage (Waterhouse-Friderichsen syndrome in septic shock)

5. Gastrointestinal Tract

• Hemorrhagic gastroenteropathy - focal mucosal hemorrhage, necrosis
• "Shock bowel" - superficial necrosis and ulceration
• Ischemic colitis

6. Liver

• Centrilobular necrosis (zone 3) - most sensitive to hypoxia as it is farthest from portal blood supply
• Fatty change

7. Lungs

• In simple hypovolemic shock: relatively resistant to hypoxic injury
• In septic or traumatic shock: Diffuse Alveolar Damage (DAD) = "Shock Lung" or ARDS (Acute Respiratory Distress Syndrome)
• Hyaline membrane formation, edema, type II pneumocyte proliferation

EVOLUTION (STAGES) OF SHOCK (5 Marks)

Stage 1: Nonprogressive (Compensated) Stage

• Reflex compensatory mechanisms are activated
• Vital organ perfusion is maintained
• Mechanisms:
  • Baroreceptor reflex activation
  • Catecholamine release → tachycardia, vasoconstriction
  • ADH and RAAS activation → fluid retention
  • Blood shunted to heart and brain (cerebral and coronary vessels less sensitive to sympathetic signals)
• Clinically: Tachycardia, peripheral vasoconstriction (cold clammy skin), maintained blood pressure
• Reversible if cause is corrected at this stage

Stage 2: Progressive Stage

• Compensatory mechanisms fail
• Widespread tissue hypoxia occurs
• Anaerobic glycolysis → lactic acidosis
• Lowered pH → arteriolar dilation → blood pools in microcirculation
• Peripheral pooling worsens cardiac output further
• Endothelial anoxic injury → DIC
• Vital organs (heart, brain, kidney, GIT) begin to fail
• Clinically: Deepening acidosis, oliguria, obtundation/altered consciousness
• Still potentially reversible with aggressive treatment

Stage 3: Irreversible Stage

• Cellular and tissue injury is so severe that even if hemodynamic defects are corrected, survival is not possible
• Lysosomal enzyme release → further cellular destruction
• Myocardial depression due to increased NO synthesis
• Intestinal bacterial translocation → bacteremia superimposed on hypovolemic shock
• Renal failure (ATN) → anuria, electrolyte imbalances, acidosis
• Multi-organ dysfunction syndrome (MODS)
• Downward spiral → death

Summary Diagram of Evolution:

RTA → Hemorrhage
       ↓
Reduced Circulating Volume
       ↓
Stage 1 (Compensated): Tachycardia, Vasoconstriction, Maintained BP
       ↓ [If untreated]
Stage 2 (Progressive): Tissue hypoxia, Lactic acidosis, DIC, Organ dysfunction
       ↓ [If untreated]
Stage 3 (Irreversible): MODS, Lysosomal leak, Bacteremia → DEATH

Clinical Outcome:

• 90% of young healthy patients with hypovolemic shock survive with prompt and appropriate management

• Prognosis worsens with septic or cardiogenic shock superimposed

Note: Harsh Mohan's Textbook of Pathology (6th/7th Ed.) covers this topic in the chapter on "Haemodynamic Disorders" - the classification (3 types), the three stages of evolution (nonprogressive, progressive, irreversible), morphology of each organ, and clinical features align exactly with the above content, which is also consistent with Robbins & Cotran Pathologic Basis of Disease.

II. SHORT NOTES - CLINICAL SCENARIO BASED QUESTIONS (6×3 = 18 Marks)

Q1. 12-year-old child, recurrent painful crises in limbs, pallor, jaundice, family history, anemia with reticulocytosis - Diagnosis, Pathogenesis, Peripheral Blood Findings (1+2+2+1) [6 Marks]

Diagnosis (1 Mark)

• Autosomal recessive hemoglobinopathy
• Family history of similar illness confirms hereditary hemolytic anemia
• Classic triad: hemolytic anemia + vaso-occlusive painful crises + splenomegaly in children

Pathogenesis (2 Marks)

• Single point mutation in the β-globin gene → Valine substituted for Glutamate at the 6th position
• Normal HbA (α₂β₂) is replaced by HbS (sickle hemoglobin)

1. On deoxygenation, HbS undergoes conformational change → forms long insoluble polymers
2. These polymers distort the RBC into an elongated, crescent/sickle shape
3. Initially reversible on reoxygenation - but repeated sickling causes irreversible membrane damage
4. Membrane damage → influx of Ca²⁺ → loss of K⁺ and water → irreversibly sickled cells

1. Chronic Hemolytic Anemia - RBC lifespan reduced to ~20 days (normal 120 days); irreversibly sickled cells are destroyed → anemia + jaundice
2. Vascular Occlusion - Sickled cells are "sticky," adhere to endothelium; sluggish blood flow in spleen and bone marrow → microinfarcts → painful vaso-occlusive crises

• Hypoxia, dehydration, acidosis, fever, infection, inflammation

Peripheral Blood Findings (2 Marks)

• Sickling test (Metabisulfite test): RBCs sickle under low O₂ conditions - positive in both trait and disease
• Hemoglobin electrophoresis: HbS band present; HbA absent in homozygous disease (HbSS)
• HPLC (High Performance Liquid Chromatography): Gold standard - quantifies HbS, HbA, HbF, HbA₂
• Serum bilirubin: Elevated (indirect/unconjugated) - from hemolysis
• Bone marrow: Erythroid hyperplasia (compensatory)

Q2. Factory worker with prolonged industrial chemical exposure develops malignant tumor - Classify chemical carcinogens with examples and how to prevent (2+2+2) [6 Marks]

Classification of Chemical Carcinogens (2 Marks)

A. DIRECT-ACTING AGENTS (No metabolic activation required)

• Definition: Act directly on DNA without needing biotransformation
• Examples:
  • Alkylating agents - Cyclophosphamide, Busulfan, Chlorambucil (chemotherapy drugs)
  • Acylating agents - Dimethyl sulphate
  • β-Propiolactone
• Note: Generally weak carcinogens; may cause secondary leukemia after use as chemotherapy

B. INDIRECT-ACTING AGENTS (Procarcinogens - require metabolic activation)

• Definition: Require metabolic conversion to an "ultimate carcinogen" by cytochrome P-450 enzymes
• Examples (with target organ cancers):

Mechanism of Action:

• Ultimate carcinogens are strong electrophiles → form DNA adducts → mutations in oncogenes and tumor suppressor genes (RAS, TP53)
• Concept of Initiation-Promotion:
  • Initiator (mutagen) = irreversible DNA damage → mutant cells
  • Promoter (e.g., phorbol esters, hormones) = stimulates clonal expansion of mutated cells
  • Promoters alone are non-tumorigenic; only effective AFTER initiation

Prevention of Chemical Carcinogenesis (2 Marks)

1. Occupational exposure control:
   • Use of personal protective equipment (PPE) - gloves, masks, protective clothing
   • Industrial hygiene measures - adequate ventilation, exhaust systems
   • Replacement of known carcinogens with safer alternatives (e.g., replace β-naphthylamine)
   • Regulatory limits for exposure (Occupational Safety & Health standards - OSHA, NIOSH)
2. Elimination/substitution:
   • Ban on highly carcinogenic dyes (azo dyes) in food and industry
   • Asbestos abatement and replacement with safer materials
3. Surveillance and monitoring:
   • Regular health checkups for workers in high-risk industries
   • Biological monitoring - measuring carcinogen metabolites in urine/blood
4. Lifestyle measures:
   • Smoking cessation (eliminates PAH and nitrosamine exposure)
   • Proper food storage to prevent Aspergillus growth → prevents aflatoxin exposure
   • Reduce consumption of processed/smoked meats
5. Antioxidants/Chemoprevention:
   • Vitamin A, C, E - may neutralize reactive intermediates
   • Selenium - protects against chemical carcinogenesis
6. Early detection:
   • Urine cytology for bladder cancer in dye/rubber workers
   • Chest X-ray/CT surveillance in asbestos-exposed workers

Q3. 22-year-old female, butterfly rash over face, joint pains, photosensitivity - Diagnosis, Other Clinical Features, Lab Diagnosis (1+2+3) [6 Marks]

Diagnosis (1 Mark)

• Chronic autoimmune multisystem inflammatory disease
• Classic presentation: Young female (F:M = 9:1 in reproductive age) + butterfly (malar) rash + photosensitivity + arthralgia
• Characterized by production of antinuclear antibodies (ANA) causing injury by immune complex deposition

Other Clinical Features (2 Marks)

Lab Diagnosis (3 Marks)

1. Autoantibody Tests (Most Important)

2. Complement Studies

• ↓ Serum C3, C4, CH50 - complement consumption by immune complexes
• Low complement levels = marker of active disease, especially active nephritis

3. Blood Counts

• Anemia - normocytic normochromic OR hemolytic (positive Direct Coombs Test)
• Leukopenia (<4000/mm³), lymphopenia
• Thrombocytopenia
• ↑ ESR (elevated in active disease)

4. Urinalysis & Renal Function

• Proteinuria (>0.5 g/24h) and hematuria - indicate lupus nephritis
• RBC casts in urine - indicate glomerulonephritis
• Elevated serum creatinine/BUN in renal involvement

5. Histopathology (Renal Biopsy)

• WHO/ISN Classification of Lupus Nephritis (Classes I-VI)
• Immunofluorescence: "Full house" pattern - IgG, IgM, IgA, C3, C1q deposits
• EM: Subendothelial and mesangial immune complex deposits
• LE bodies / Hematoxylin bodies in tissues - homogeneous nuclear material from cells reacting with ANA
• LE cell (historically) - phagocyte that has engulfed denatured nucleus (positive in vitro agitation test)

6. Other Tests

• VDRL/RPR - false positive (due to antiphospholipid antibodies)
• ↑ Serum immunoglobulins (hypergammaglobulinemia)
• CRP - often normal (unlike RA/bacterial infection); useful to distinguish infection flare from lupus flare
• Skin biopsy - Lupus band test: IgG/C3 deposits at dermoepidermal junction (positive in both involved and uninvolved skin in SLE)

Note on Reference: Harsh Mohan's Textbook of Pathology (7th Ed.) covers these topics in:

• Chapter 12: Disorders of Red Blood Cells (Sickle Cell Anemia)
• Chapter 8: Neoplasia - Chemical Carcinogens
• Chapter 4: Diseases of Immunity - SLE The content above is fully consistent with Harsh Mohan's framework and aligns with Robbins & Cotran Pathologic Basis of Disease.